Author

Arnaud Augert

Yale Cancer CenterORCID 0000-0003-0636-3024Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Ali H. IbrahimiD· 1 shared Brian W. FreieiD· 1 shared Danielle K. SohaiiD· 1 shared David P MacPhersoniD· 1 shared Jon S. MorrowiD· 1 shared Michael C. StankewichiD· 1 shared Mileena T. NguyeniD· 1 shared Nancy Chen· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ali H. IbrahimORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintFeb 17, 2026

Nanobody MET CAR T cells show efficacy in solid tumors

Po‐Han Chen, Qin Li, Sam Deveraux…·Samuel G. Katz

This study demonstrates that MET-targeting VHH-CAR-T cells effectively kill tumor cells in vitro and control tumor growth in vivo.

DOI 10.64898/2026.01.27.702111

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologyScience AdvancesPeer-reviewedApr 25, 2025

MAX inactivation deregulates the MYC network and induces neuroendocrine neoplasia in multiple tissues

Brian W. Freie, Ali H. Ibrahim, Patrick A. Carroll…·Robert N. Eisenman

This study shows that MAX inactivation disrupts the MYC network, leading to neuroendocrine tumors in multiple tissues by altering transcription factor balance.

18 citationstop 2%

mouseDNA methylation

𝕏 PostBluesky